Effect of discontinuation of growth hormone treatment on risk factors for cardiovascular disease in adolescents born small for gestational age

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 1, 2003, Pages 347-353

  Van Pareren, Yvonne ^a   Mulder, Paul ^b   Houdijk, Mieke ^c   Jansen, Maarten ^d   Reeser, Maarten ^e   Hokken Koelega, Anita ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e JULIANA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; GROWTH HORMONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID;

ADOLESCENT; AREA UNDER THE CURVE; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; MALE; PRIORITY JOURNAL; SMALL FOR DATE INFANT; SYSTOLIC BLOOD PRESSURE; TREATMENT WITHDRAWAL;

ADOLESCENT; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLUCOSE TOLERANCE TEST; GROWTH HORMONE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; INSULIN; LIPIDS; MALE; RISK FACTORS;

EID: 0037242838     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-020458     Document Type: Article

References (47)

1. Wadsworth ME, Cripps HA, Midwinter RE, Colley JR 1985 Blood pressure in a national birth cohort at the age of 36 related to social and familial factors, smoking, and body mass. Br Med J (Clin Res Ed) 291:1534-1538
2. Barker DJ, Osmond C, Simmonds SJ, Wield GA 1993 The relation of small head circumference and thinness at birth to death from cardiovascular disease in adult life. Br Med J 306:422-426
3. Barker DJ, Hales CN, Fall CH, Osmond C, Phipps K, Clark PM 1993 Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 36:62-67
4. Barker DJ 1997 The fetal origins of coronary heart disease. Acta Paediatr Suppl 422:78-82
5. Hokken-Koelega AC, de Ridder MA, Lemmen RJ, den Hartog H, de Muinck Keizer-Schrama SM, Drop SL 1995 Children born small for gestational age: do they catch up? Pediatr Res 38:267-271
6. Albertsson-Wikland K, Karlberg J 1994 Natural growth in children born small for gestational age with and without catch-up growth. Acta Paediatr Suppl 399:64-70; discussion 71
7. Sas T, de Waal W, Mulder P, Houdijk M, Jansen M, Reeser M, Hokken-Koelega A 1999 Growth hormone treatment in children with short stature born small for gestational age: 5-year results of a randomized, double-blind, doseresponse trial. J Clin Endocrinol Metab 84:3064-3070
8. De Zegher F, Albertsson-Wikland K, Wollmann HA, Chatelain P, Chaussain JL, Lofstrom A, Jonsson B, Rosenfeld RG 2000 Growth hormone treatment of short children born small for gestational age: growth responses with continuous and discontinuous regimens over 6 years. J Clin Endocrinol Metab 85:2816-2821
9. Davidson MB 1987 Effect of growth hormone on carbohydrate and lipid metabolism. Endocr Rev 8:115-131
10. Cutfield WS, Wilton P, Bennmarker H, Albertsson-Wikland K, Chatelain P, Ranke MB, Price DA 2000 Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment. Lancet. 355:610-613
11. Sas T, Mulder P, Aanstoot HJ, Houdijk M, Jansen M, Reeser M, Hokken-Koelega A 2001 Carbohydrate metabolism during long-term growth hormone treatment in children with short stature born small for gestational age. Clin Endocrinol (Oxf) 54:243-251
12. Sas T, Mulder P, Hokken-Koelega A 2000 Body composition, blood pressure, and lipid metabolism before and during long-term growth hormone (GH) treatment in children with short stature born small for gestational age either with or without GH deficiency. J Clin Endocrinol Metab 85:3786-3792
13. De Waal WJ, Hokken-Koelega AC, Stijnen T, de Muinck Keizer-Schrama SM, Drop SL 1994 Endogenous and stimulated GH secretion, urinary GH excretion, and plasma IGF-I and IGF-II levels in prepubertal children with short stature after intrauterine growth retardation. The Dutch Working Group on Growth Hormone. Clin Endocrinol (Oxf) 41:621-630
14. Cameron N The methods of auxological anthropometry. In: Falkner F, Tanner JM, eds. Human growth: postnatal growth. London: Tindall; 1978:35-90
15. Roede MJ, van Wieringen JC 1985 Growth diagrams 1980. Netherlands third nation-wide survey. Tijdschr Soc Gezondh 63(Suppl 1):1-34
16. Task Force on Blood Pressure Control in Children 1987 Report of the Second Task Force on Blood Pressure Control in Children - 1987. National Heart, Lung, and Blood Institute, Bethesda, Maryland. Pediatrics 79:1-25
17. Tanner JM, Whitehouse RH 1976 Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 51:170-179
18. 1997 Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Diabetes Care 20:1183-1197
19. Potau N, Ibanez L, Rique S, Carrascosa A 1997 Pubertal changes in insulin secretion and peripheral insulin sensitivity. Horm Res 48:219-226
20. Uiterwaal CS, Witteman JC, de Bruijn AM, Hofman A, Grobbee DE 1997 Families and natural history of lipids in childhood: an 18-year follow-up study. Am J Epidemiol 145:777-785
21. Gent CM, Voort HA, Bruyn AM, Klein F 1977 Cholesterol determinations: a comparative study of methods with special reference to enzymatic procedures. Clin Chim Acta 75:243-251
22. Grove TH 1979 Effect of reagent pH on determination of high-density lipoprotein cholesterol by precipitation with sodium phosphotungstate-magnesium. Clin Chem 25:560-564
23. Saenger P, Attie KM, DiMartino-Nardi J, Fine RN 1996 Carbohydrate metabolism in children receiving growth hormone for 5 years. Chronic renal insufficiency compared with growth hormone deficiency, Turner syndrome, and idiopathic short stature. The Genentech Collaborative Group. Pediatr Nephrol 10:261-263
24. Sas TC, de Muinck Keizer-Schrama SM, Stijnen T, Aanstoot HJ, Drop SL 2000 Carbohydrate metabolism during long-term growth hormone (GH) treatment and after discontinuation of GH treatment in girls with Turner syndrome participating in a randomized dose-response study. Dutch Advisory Group on Growth Hormone. J Clin Endocrinol Metab 85:769-775
25. Reaven GM, Brand RJ, Chen YD, Mathur AK, Goldfine I 1993 Insulin resistance and insulin secretion are determinants of oral glucose tolerance in normal individuals. Diabetes. 42:1324-1332
26. Lesage C, Walker J, Landier F, Chatelain P, Chaussain JL, Bougneres PF 1991 Near normalization of adolescent height with growth hormone therapy in very short children without growth hormone deficiency. J Pediatr 119:29-34
27. Bareille P, Azcona C, Matthews DR, Conway GS, Stanhope R 1999 Lipid profile, glucose tolerance and insulin sensitivity after more than four years of growth hormone therapy in non-growth hormone deficient adolescents. Clin Endocrinol (Oxf) 51:347-353
28. Bloch CA, Clemons P, Sperling MA 1987 Puberty decreases insulin sensitivity. J Pediatr 110:481-487
29. Cutfield WS, Bergman RN, Menon RK, Sperling MA 1990 The modified minimal model: application to measurement of insulin sensitivity in children. J Clin Endocrinol Metab 70:1644-1650
30. Travers SH, Jeffers BW, Bloch CA, Hill JO, Eckel RH 1995 Gender and Tanner stage differences in body composition and insulin sensitivity in early pubertal children. J Clin Endocrinol Metab 80:172-178
31. Reaven GM, Moore J, Greenfield M 1983 Quantification of insulin secretion and in vivo insulin action in nonobese and moderately obese individuals with normal glucose tolerance. Diabetes 32:600-604
32. Leger J, Levy-Marchal C, Bloch J, Pinet A, Chevenne D, Porquet D, Collin D, Czernichow P 1997 Reduced final height and indications for insulin resistance in 20 year olds born small for gestational age: regional cohort study. Br Med J 315:341-347
33. Jaquet D, Gaboriau A, Czernichow P, Levy-Marchal C 2000 Insulin resistance early in adulthood in subjects born with intrauterine growth retardation. J Clin Endocrinol Metab 85:1401-1406
34. Hofman PL, Cutfield WS, Robinson EM, Bergman RN, Menon RK, Sperling MA, Gluckman PD 1997 Insulin resistance in short children with intrauterine growth retardation. J Clin Endocrinol Metab 82:402-406
35. Chiarelli F, di Ricco L, Mohn A, De Martino M, Verrotti A 1999 Insulin resistance in short children with intrauterine growth retardation. Acta Paediatr Suppl 428:62-65
36. Phipps K, Barker DJ, Hales CN, Fall CH, Osmond C, Clark PM 1993 Fetal growth and impaired glucose tolerance in men and women. Diabetologia 36:225-228
37. Johannsson G, Albertsson-Wikland K, Bengtsson BA 1999 Discontinuation of growth hormone (GH) treatment: metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects. Swedish Study Group for Growth Hormone Treatment in Children. J Clin Endocrinol Metab 84:4516-4524
38. Hashimoto N, Kawasaki T, Kikuchi T, Takahashi H, Uchiyama M 1996 The relationship between the intrauterine environment and blood pressure in 3-year-old Japanese children. Acta Paediatr 85:132-138
39. Pharoah PO, Stevenson CJ, West CR 1998 Association of blood pressure in adolescence with birthweight. Arch Dis Child Fetal Neonatal Ed 79:F114-F118
40. Yiu V, Buka S, Zurakowski D, McCormick M, Brenner B, Jabs K 1999 Relationship between birthweight and blood pressure in childhood. Am J Kidney Dis 33:253-260
41. Leon DA, Johansson M, Rasmussen F 2000 Gestational age and growth rate of fetal mass are inversely associated with systolic blood pressure in young adults: an epidemiologic study of 165,136 Swedish men aged 18 years. Am J Epidemiol 152:597-604
42. Uiterwaal CS, Anthony S, Launer LJ, Witteman JC, Trouwborst AM, Hofman A, Grobbee DE 1997 Birth weight, growth, and blood pressure: an annual follow-up study of children aged 5 through 21 years. Hypertension 30:267-271
43. Vahl N, Juul A, Jorgensen JO, Orskov H, Skakkebaek NE, Christiansen JS 2000 Continuation of growth hormone (GH) replacement in GH-deficient patients during transition from childhood to adulthood: a two-year placebo-controlled study. J Clin Endocrinol Metab 85:1874-1881
44. Kuromaru R, Kohno H, Ueyama N, Hassan HM, Honda S, Hara T 1998 Long-term prospective study of body composition and lipid profiles during and after growth hormone (GH) treatment in children with GH deficiency: gender-specific metabolic effects. J Clin Endocrinol Metab 83:3890-3896
45. Van Stiphout WA, Hofman A, de Bruijn AM, Valkenburg HA 1985 Distributions and determinants of total and high-density lipoprotein cholesterol in Dutch children and young adults. Prev Med 14:169-180
46. Hickman TB, Briefel RR, Carroll MD, Rifkind BM, Cleeman JI, Maurer KR, Johnson CL 1998 Distributions and trends of serum lipid levels among United States children and adolescents ages 4-19 years: data from the Third National Health and Nutrition Examination Survey. Prev Med 27:879-890
47. Lundgren EM, Cnattingius HM, Jonsson GB, Tuvemo TH 2001 Linear catch-up growth does not increase the risk of elevated blood pressure and reduces the risk of overweight in males. J Hypertens 19:1533-1538